Pharmaceuticals

600+ Companies
Companies
664
Established hub
Deals 2018 Q3
21 investments
2 acquisitions
Index Pro Account
Upgrade your account to download a CSV export of companies on any list
FinSMEs

Checkmate Pharmaceuticals Closes $22M Financing

Xconomy

To Cover Debts, Synergy Inks $200M Bankruptcy Sale to Bausch Health

$18,000,000 Venture capital (Series A)
PE Hub

Spring Discovery rallies $18 mln Series A

Xconomy

Roche Vet O’Day Tapped To Shape Gilead’s Future As Hep C Sales Fall

MedCity News

Imfinzi looks flimsy in AstraZeneca's Phase III head and neck cancer study

Xconomy

Viracta, Neurelis & More: The Latest in San Diego Biotech

$21,000,000 Venture capital (Series B)
FinSMEs , PE Hub

Kallyope Raises $21M Expansion of Series B Financing

Venture capital (Series A)
FinSMEs

Vast Therapeutics Closes Series A Funding

PE Hub

GSK slides after buying cancer firm Tesaro for hefty $5.1 billion: Reuters

€1,200,000 Crowdfunding
novobrief

AbilityPharma raises €1.2M to develop drug for cancer

FinSMEs

Variant Pharmaceuticals Secures $10M in Financing

VCCircle Network

Unilever wins race for GSK's consumer healthcare biz in India

PE Hub

Hildred-backed Crown Laboratories acquires five OTC consumer brands from GSK

$30,000,000 Venture capital
FinSMEs

Nevakar Completes $30M Financing

$30,000,000 Venture capital (Series B)
Xconomy

Shine Raises $30M, Could Add $150M More After Inking Deerfield Deal

PE Hub

VC-backed Rgenix expands board with new addition

Xconomy

X4 Pharma Heads to Nasdaq Via Reverse Merger with Arsanis

PE Hub

VC-backed BlueRock Therapeutics names chief legal and administrative officer

MedCity News

Centrexion Therapeutics changes its mind on initial public offering

MedCity News

AstraZeneca sells US rights to RSV drug to Swedish firm for $1.5B